The Board granted an initial rating of 60 percent for prostate cancer residuals prior to November 14, 2024, but denied a higher rating since that date.

The deciding factor: The decision was based on the Veteran's voiding dysfunction requiring absorbent materials changed more than four times per day, with no evidence of renal dysfunction or other factors warranting a higher rating.

Claimed conditions

prostate cancer residuals

How they argued it

Direct service connection

Exposure basis

None

Rating assigned

60%

Decision date

November 4, 2025

Citation

A25095832

Want to see how appeals like this one tend to go? Appeals like mine